• Western blot analysis of lysates from DU145 cells, primary antibody was diluted at 1:1000, 4°C over night

Anti-FGFBP2 antibody (170-219 aa) (STJ93065)

SKU:
STJ93065

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Rat/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Fibroblast growth factor-binding protein 2 (170-219 aa) is suitable for use in Western Blot and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
ELISA 1:40000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: FGFBP2
Gene ID: 83888
Uniprot ID: FGFP2_HUMAN
Immunogen Region: 170-219 aa
Specificity: FGF-BP2 Polyclonal Antibody detects endogenous levels of FGF-BP2 protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human FGFP2 at the amino acid range 170-219
Protein Name Fibroblast Growth Factor-Binding Protein 2
Fgf-Bp2
Fgf-Binding Protein 2
Fgfbp-2
37 Kda Killer-Specific Secretory Protein
Ksp37
Hbp17-Related Protein
Hbp17-Rp
Database Links Reactome: R-HSA-190377
Cellular Localisation Secreted
Extracellular Space
Alternative Antibody Names Anti-Fibroblast Growth Factor-Binding Protein 2 antibody
Anti-Fgf-Bp2 antibody
Anti-Fgf-Binding Protein 2 antibody
Anti-Fgfbp-2 antibody
Anti-37 Kda Killer-Specific Secretory Protein antibody
Anti-Ksp37 antibody
Anti-Hbp17-Related Protein antibody
Anti-Hbp17-Rp antibody
Anti-FGFBP2 antibody
Anti-KSP37 antibody
Anti-UNQ425 antibody
Anti-PRO1065 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance